PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+40.67%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$415M
AUM Growth
+$415M
(+6.3%)
Cap. Flow
-$37.8M
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
39.8%
Holding
104
New
20
Increased
36
Reduced
26
Closed
21
Top Buys
| 1 |
United Therapeutics
UTHR
|
$12.5M |
| 2 |
Amgen
AMGN
|
$11.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.08M |
| 4 |
Danaher
DHR
|
$3.89M |
| 5 |
EDAP
EDAP TMS
EDAP
|
$3.73M |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$16.2M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.87M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.41M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$9.02M |
| 5 |
Schrodinger
SDGR
|
$8.82M |
Sector Composition
| 1 | Healthcare | 95.8% |
| 2 | Technology | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$374B
| – | – |
-30,000
| Closed | -$3.22M |
|
102
Altimmune
ALT
$325M
| – | – |
-100,000
| Closed | -$1.13M |
|
103
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-30,758
| Closed | -$2.51M |
|
104
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-25,000
| Closed | -$2.19M |
|